Peptide Mutant promoters of T Cell Immunity, Pharmaceutical compositions and Vaccines made with these peptides for the treatment of cancers; use of these PeptidesMethod for identifying these peptides and DNA sequences encoding such peptides and Plasmid Vectors and Mutants

摘要

This is a peptide for the production of T-cell immunity, which includes: (a) a part of at least 8 amino acids, extracted from a mutated protein read from the gel of carcinogenic cells; (b) an amino acid with at least one mutated part, a mutated part of the protein sequence synthesized by the gene; (c) It consists of 0 to 10 amino acids, which are the carbohydrate tips of the normal part of the protein sequence, before the extreme hormones of the variant sequence, and may further diffuse to the carbohydrate tips of the protein variant part, the latter being determined by a new pore diameter generated by the transformed framework. Read;(d) Whether in longitude or after antigen generator treatment, T lymphocyte response was induced.